EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Chemical constituents from a marine medicinal brown alga-derived Xylaria acuta SC1019

Hsiao-Yang Hsi, Shih-Wei Wang, George Hsiao, Li-Kwan Chang, Yuan-Chung Cheng, Shu-Jung Huang, Yi-Shan Lu, Tzong-Huei Lee

Journal of Food and Drug Analysis · 10.06.2024 · 32 (2) · 161-173

DOI: 10.38212/2224-6614.3501 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Food and Drug Analysis, online erschienen am 10.06.2024. Verfasst von Hsiao-Yang Hsi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Fisheries Science, National Taiwan University, Taipei 106, Taiwan. Hauptthemen laut MEDLINE: Xylariales. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, a marine medicinal brown alga Sargassum cristaefolium-derived fungal strain Xylaria acuta SC1019 was isolated and identified. Column chromatography of the extracts from liquid- and solid-fermented products of the fungal strain was carried out, and led to the isolation of twenty-one compounds. Their structures were characterized by spectroscopic analysis, and the absolute configurations were further established by single X-ray diffraction analysis or modified Mosher’s method as nine previously undescribed compounds, namely xylarilactones A–C (1–3), ent-gedebic acid 8-O-α-D-glucopyranoside (4), 5R-hydroxylmethylmellein 11-O-α-D-glucopyranoside (5), ent-hymatoxin E 16-O-α-D-mannopyranoside (6), 19,20-epoxycytochalasin S (7), 19,20-epoxycytochalasin T (8), and (2R)-butylitaconic acid (9), along with twelve known compounds 10–21. All the isolates were subjected to anti-inflammatory and anti-angiogenic assays. Compounds 1, 5, 7, 10, and 17 showed moderate nitric oxide production inhibitory activities in lipopolysaccharide-activated BV-2 microglial cells with IC50 values of 19.55 ± 0.35, 16.10 ± 0.57, 15.20 ± 0.87, 11.76 ± 0.49, and 11.30 ± 0.32 μM, respectively, as compared to curcumin (IC50 = 2.69 ± 0.34 μM) without any significant cytotoxicity. Compounds 7, 8, and 21 displayed potent anti-angiogenic activities by suppressing the growth of human endothelial progenitor cells with IC50 values of 0.44 ± 0.01, 0.47 ± 0.03, and 0.53 ± 0.01 μM, respectively, as compared to sorafenib (IC50 = 5.50 ± 1.50 μM).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

XylarialesHumansAnimalsMiceMolecular StructurePhaeophyceaeAnti-Inflammatory AgentsCell Line

Substanzen

Anti-Inflammatory Agents

Autor:innen und Institutionen

  • Institute of Fisheries Science, National Taiwan University, Taipei 106, Taiwan.
  • Institute of Biomedical Sciences, MacKay Medical College, New Taipei City 252, Taiwan.
  • Department of Medicine, MacKay Medical College, New Taipei City 252, Taiwan.
  • Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
  • Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.
  • Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.

Zitieren

APA

Hsi, H. Y., Wang, S. W., Hsiao, G., Chang, L. K., Cheng, Y. C., Huang, S. J., Lu, Y. S., & Lee, T. H. (2024). Chemical constituents from a marine medicinal brown alga-derived Xylaria acuta SC1019. Journal of Food and Drug Analysis, 32(2), 161-173. https://doi.org/10.38212/2224-6614.3501

Vancouver

Hsi HY, Wang SW, Hsiao G, Chang LK, Cheng YC, Huang SJ, et al. Chemical constituents from a marine medicinal brown alga-derived Xylaria acuta SC1019. Journal of Food and Drug Analysis. 2024;32(2):161-173. doi:10.38212/2224-6614.3501

BibTeX
@article{Hsi2024,
  author = {Hsi, Hsiao-Yang and Wang, Shih-Wei and Hsiao, George and Chang, Li-Kwan and Cheng, Yuan-Chung and Huang, Shu-Jung and Lu, Yi-Shan and Lee, Tzong-Huei},
  title = {Chemical constituents from a marine medicinal brown alga-derived Xylaria acuta SC1019},
  journal = {Journal of Food and Drug Analysis},
  year = {2024},
  volume = {32},
  number = {2},
  pages = {161--173},
  doi = {10.38212/2224-6614.3501}
}
Kostenlos starten →